Status:
COMPLETED
Smart Sensory Technology in Psychotherapy for Pediatric OCD
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Universität Tübingen
University of Hohenheim
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
Telemedicine interventions enable the improvement of behavioral state-of-the-art treatment of OCD, as therapy can be delivered in the patients' immediate home environment, allowing for more valid symp...
Detailed Description
The main goal of SSTeP-KiZ is the implementation of sensors in the existing telepsychotherapeutic treatment of children and adolescents with obsessive-compulsive disorder. SSTeP-KiZ aims to significan...
Eligibility Criteria
Inclusion
- children and adolescents with obsessive-compulsive disorders
- aged 12 to 18 years
- a primary DSM-5 obsessive-compulsive disorder
- at least one primary caretaker
- German-speaking (child \& caretakers)
- family home equipped with broadband internet connection
- written informed consent of the child and its caretakers
- psychiatric comorbidities will be allowed as long as the comorbid disorder does not have a higher treatment priority than OCD (i.e., psychosis, eating disorder and severe depression)
- Medication is allowed if treatment was stable for 6 weeks before diagnostics and will then be taken during the trial.
Exclusion
- IQ below 70
- patients do not speak or understand German
- patients have a psychiatric comorbidity or suicidality that makes participation clinically inappropriate
- too seriously ill so that they should be treated in the hospital
- stable social environment, able to support the children adequately during therapy. - drug addiction
- if the family seems to be severely psychologically burdened so that participation in the sessions and support of the children during the trial will not be possible
- no other psychological treatment is allowed
- If reporting side effects or circumstances that make iCBT treatment clinically inappropriate, or if wished by the patients, the patients are excluded from the study and transferred to another more appropriate therapy option.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05291611
Start Date
August 1 2021
End Date
March 31 2023
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
Tübingen, Baden-Wurttemberg, Germany, 72076